Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0000875320-26-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | VRTX | Liu Joy | EVP, CLO | S - Sale | $495.96 | -892 | 22.8K | -4% | -$442.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 892 | $495.96 | 22,811 | D | — | — |